Contents

Current Cancer Therapy Reviews, Volume 11 - Number 4

Meet Our Editorial Board Member:

, 11(4): 199

Robert Clarke


DOI: 10.2174/157339471104160328123342




Editorial

Editorial (Thematic Issue: Chemoresistance in Gynecologic Cancers)

, 11(4): 200

Daniel R. Ciocca and Tamara Kalir


DOI: 10.2174/157339471104160328124437




The Involvement of Heat Shock Proteins and Related Molecules in the Resistance to Therapies in Breast and Gynecologic Cancer

, 11(4): 201 - 221

F. Darío Cuello-Carrión, Mariel A. Fanelli, Gisela N. Castro, Niubys Cayado-Gutiérrez and Daniel R. Ciocca


DOI: 10.2174/1573394712666151215213709




New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways

, 11(4): 222 - 259

John P. Schwerkoske and Douglas Yee


DOI: 10.2174/1573394712666151215220005




Chemotherapy Resistance in Breast Cancer

, 11(4): 260 - 268

Polly Niravath and Julie Nangia


DOI: 10.2174/1573394712666151215220204




Understanding Trastuzumab Resistance in HER2 Positive Breast Cancer and Further Therapeutic Options

, 11(4): 269 - 291

Sangmee Bae and Sara Hurvitz


DOI: 10.2174/1573394712666151119213606




Treatment of Uterine Carcinomas

, 11(4): 292 - 299

Mary Chu, Estrelania Williams, D. Stave Kohtz, Tamara Kalir and David Fishman


DOI: 10.2174/1573394712666151119213759




Treatment of High-Grade Pelvic-Type Serous Carcinomas (Ovary, Fallopian Tube and Peritoneum): Current Therapeutic Paradigms, Prospects, and Challenges

, 11(4): 300 - 313

Mary Chu, D. Stave Kohtz, Estrelania Williams, Tamara Kalir and David Fishman


DOI: 10.2174/1573394712666151119213935




Current Strategies and Future Directions in Classification and Treatment of Uterine Sarcomas

, 11(4): 314 - 322

Mary Chu, D. Stave Kohtz, Estrelania Williams, Tamara Kalir and David Fishman


DOI: 10.2174/1573394712666151119214053




Acknowledgements to Reviewers:

, 11(4): 323


DOI: 10.2174/157339471104160328142738




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science